TechSeeker Profile

Aclaris Therapeutics Inc
Profile last edited on: 3/30/2023

NO Business Identifier is currently available for this company.
TS Type
Small Corp
Status
Active
Year Founded
2012
Last Involved Year
2017

Key People / Management

  Neal S Walker -- Co-Founder & Chairman

  Joseph Monahan -- Chief Scientific Officer

Location Information

640 Lee Road Suite 200
Wayne, PA 19087
   (484) 324-7933
   www.aclaristx.com

Public Profile

Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments, Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment offers laboratory services. The company develops Zunsemetinib, an MK2 inhibitor for the treatment of moderate to severe rheumatoid and Psoriatic arthritis, and Hidradenitis suppurativa; and ATI-1777, a soft JAK 1/3 inhibitor for the treatment of moderate to severe atopic dermatitis. It develops ATI-2138, an ITK/TXK/JAK3 inhibitor as a potential treatment for T cell-mediated autoimmune diseases; Gut-Biased Program for inflammatory bowel disease; and ATI-2231, an oral MK2 inhibitor for the treatment of pancreatic and metastatic breast cancer. Aclaris Therapeutics, Inc. was incorporated in 2012 and is headquartered in Wayne, Pennsylvania.

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Headquartered
USA
Employment
100
Revenue
$7.8M
Public/Private
Publicly Traded
Stock Info
NASDAQ : ACRS
Received SBIR $$
No

Techseeker firm in the news

There are no news available.